Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury

抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制

基本信息

项目摘要

ABSTRACT Neuroinflammation has emerged as a critical component of secondary injury and disease progression following brain trauma. Recent pre-clinical studies have shed light on the neurotoxic effects of peripheral innate immunity. Our preliminary findings suggest this overzealous response may be mediated by EphA4/mTOR signaling which negatively regulates the anti-inflammatory state of peripheral-derived monocyte/macrophages (PDMs). The research objective of this application is to characterize the cellular and molecular mechanism(s) underlying innate immunity and PDM polarization status in the regulation of tissue damage and functional recovery following TBI. Our proposal builds upon extensive preliminary and published data demonstrating a distinct protective and reduced pro-inflammatory response in the absence of peripheral EphA4 using chimeric mice following controlled cortical impact (CCI) injury. Interestingly, PDMs-derived from EphA4null mice directly confer neuroprotection and blood brain-barrier preservation in a model of monocyte depletion and replacement. Moreover, we discovered that PDM-specific EphA4 suppresses phosphorylation of key proteins involved in the mTOR pathway, a novel mediator of the pro-resolving state of PDMs. We hypothesize that EphA4 mediates the pro-inflammatory innate immune response by suppressing mTOR signaling, which induces PDM infiltration, polarization and phenotypic behaviors that drive neurovascular dysfunction following TBI. We will employ cell-specific depletions, and PDM replacement as well as novel transgenic murine models. These approaches will include rigorous behavioral, histological and innovative low-input genome-wide epigenomic and transcriptomic assessment of the relevance and mechanism(s) of PDM behaviors. We will also provide a framework for retooling the neuroinflammatory response to accelerate recovery and dampen pro-inflammatory processes after TBI.
摘要 神经炎症已经成为继发性损伤和疾病进展的关键组成部分, 脑外伤最近的临床前研究揭示了外周先天免疫的神经毒性作用。 我们的初步发现表明这种过度反应可能是由EphA 4/mTOR信号传导介导的, 负调节外周来源的单核细胞/巨噬细胞(PDM)的抗炎状态。的 本申请的研究目的是表征细胞和分子机制, 先天免疫和PDM极化状态在组织损伤和功能恢复的调节中的作用 创伤性脑损伤我们的建议是建立在广泛的初步和已发表的数据基础上的,这些数据表明, 使用嵌合小鼠,在不存在外周EphA 4的情况下, 皮质撞击(CCI)损伤。有趣的是,源自EphA 4缺失小鼠的PDM直接赋予神经保护作用, 在单核细胞耗竭和替代模型中的血脑屏障保存。此外,我们发现, PDM特异性EphA 4抑制参与mTOR通路的关键蛋白的磷酸化,这是一种新的 调解人的前解决状态的PDM。我们假设EphA 4介导促炎性先天性炎症反应, 通过抑制mTOR信号传导,诱导PDM浸润、极化和表型分化, 导致脑外伤后神经血管功能障碍的行为。我们将采用细胞特异性耗竭, 替代以及新的转基因鼠模型。这些方法将包括严格的行为, 组织学和创新的低输入全基因组表观基因组学和转录组学评估的相关性 和PDM行为的机制。我们还将提供一个框架, 反应,以加速恢复和抑制促炎过程后TBI。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michelle Lee Theus其他文献

Michelle Lee Theus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michelle Lee Theus', 18)}}的其他基金

Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
  • 批准号:
    10183562
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Divergent age-dependent peripheral innate immune response following TBI
TBI 后不同年龄依赖性外周先天免疫反应
  • 批准号:
    10427434
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
  • 批准号:
    10814445
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
  • 批准号:
    10409794
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Divergent age-dependent peripheral innate immune response following TBI
TBI 后不同年龄依赖性外周先天免疫反应
  • 批准号:
    10295232
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Divergent age-dependent peripheral innate immune response following TBI
TBI 后不同年龄依赖性外周先天免疫反应
  • 批准号:
    10653859
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Novel mechanisms suppressing pro-resolving innate immunity following traumatic brain injury
抑制创伤性脑损伤后先天免疫的新机制
  • 批准号:
    10572099
  • 财政年份:
    2021
  • 资助金额:
    $ 40万
  • 项目类别:
Novel Cellular and Molecular Regulation of Collateral Remodeling in Ischemic Stroke
缺血性中风侧枝重塑的新型细胞和分子调节
  • 批准号:
    10452552
  • 财政年份:
    2019
  • 资助金额:
    $ 40万
  • 项目类别:
Novel Cellular and Molecular Regulation of Collateral Remodeling in Ischemic Stroke
缺血性中风侧枝重塑的新型细胞和分子调节
  • 批准号:
    10197241
  • 财政年份:
    2019
  • 资助金额:
    $ 40万
  • 项目类别:
Novel Cellular and Molecular Regulation of Collateral Remodeling in Ischemic Stroke
缺血性中风侧枝重塑的新型细胞和分子调节
  • 批准号:
    10642764
  • 财政年份:
    2019
  • 资助金额:
    $ 40万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 40万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 40万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了